Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00329472
Status:
WITHDRAWN
Last Update Posted:
2010-08-27
First Post:
2006-05-22
Brief Title:
Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Study Overview
Official Title:
Randomized Phase III Trial of Neoadjuvant Chemotherapy Followed by Surgery Plus Adjuvant Chemotherapy Versus Surgery Plus Adjuvant Chemotherapy in Stage IB IIA IIB and T3N1 Non-small Cell Lung Cancer ICON
Status:
WITHDRAWN
Status Verified Date:
2010-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
poor enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is randomized phase III trial designed to assess whether preoperative neoadjuvant chemotherapy followed by surgery plus adjuvant chemotherapy with gemcitabine and cisplatin experimental treatment improves 3-year disease-free survival compared to surgery plus adjuvant chemotherapy with gemcitabine and cisplatin standard treatment in stage IB IIA IIB and T3N1 non-small cell lung cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None